Objectives: To compare the clinical and microbiological outcomes of patients treated with beta-lactam monotherapy or combination therapy for Pseudomonas aeruginosa infections. Data sources: MEDLINE, Google Scholar and the Cochrane Library.Study eligibility criteria and interventions: Experimental and observational studies published as full papers up to December 2020 that compared the efficacy of beta-lactams used as monotherapy or in combination with other active agents as empirical or targeted therapy for bloodstream infections or hospital-acquired pneumonia/ventilator-associated pneumonia due to P. aeruginosa were included in this meta-analysis. The outcomes evaluated were in-hospital mortality rate, 14 -day-or 30-day-mortality rate, micr...
ObjectivesManagement of bloodstream infections (“BSIs”) caused by Pseudomonas aeruginosa remains con...
Ineffective antimicrobial therapy of Pseudomonas aeruginosa bacteraemia increases mortality. Recent ...
Objective: Explore literature comparing the pharmacokinetic and clinical outcomes from addition of p...
Objectives: To compare the clinical and microbiological outcomes of patients treated with beta-lacta...
Objectives: To compare the clinical and microbiological outcomes of patients treated with beta-lacta...
Background: Bacteremia by Pseudomonas aeruginosa represents one severe infection. It is not clear wh...
OBJECTIVES:Management of bloodstream infections ("BSIs") caused by Pseudomonas aeruginosa remains co...
[Background] Pseudomonas aeruginosa bacteraemia is a common and serious infection. No consensus exis...
This study was presented as poster presentation at the European Society of Clinical Microbiology and...
BACKGROUND: The optimal antibiotic regimen for Pseudomonas aeruginosa bacteremia is controversial. A...
International audienceAbstract Background Pseudomonas aeruginosa bacteraemia is a common and serious...
Pseudomonas aeruginosa bacteremia is associated with high hospital mortality. Empirical combination ...
represents one severe infection. It is not clear whether beta-lactam monotherapy leads to similar r...
To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neu...
To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neu...
ObjectivesManagement of bloodstream infections (“BSIs”) caused by Pseudomonas aeruginosa remains con...
Ineffective antimicrobial therapy of Pseudomonas aeruginosa bacteraemia increases mortality. Recent ...
Objective: Explore literature comparing the pharmacokinetic and clinical outcomes from addition of p...
Objectives: To compare the clinical and microbiological outcomes of patients treated with beta-lacta...
Objectives: To compare the clinical and microbiological outcomes of patients treated with beta-lacta...
Background: Bacteremia by Pseudomonas aeruginosa represents one severe infection. It is not clear wh...
OBJECTIVES:Management of bloodstream infections ("BSIs") caused by Pseudomonas aeruginosa remains co...
[Background] Pseudomonas aeruginosa bacteraemia is a common and serious infection. No consensus exis...
This study was presented as poster presentation at the European Society of Clinical Microbiology and...
BACKGROUND: The optimal antibiotic regimen for Pseudomonas aeruginosa bacteremia is controversial. A...
International audienceAbstract Background Pseudomonas aeruginosa bacteraemia is a common and serious...
Pseudomonas aeruginosa bacteremia is associated with high hospital mortality. Empirical combination ...
represents one severe infection. It is not clear whether beta-lactam monotherapy leads to similar r...
To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neu...
To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neu...
ObjectivesManagement of bloodstream infections (“BSIs”) caused by Pseudomonas aeruginosa remains con...
Ineffective antimicrobial therapy of Pseudomonas aeruginosa bacteraemia increases mortality. Recent ...
Objective: Explore literature comparing the pharmacokinetic and clinical outcomes from addition of p...